Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 17 Beta-acetoxyestra-4,9,11-trien-3-one
2. Acetate, Trenbolone
3. Acetate, Trienbolone
4. Progro T S
5. Progro T-s
6. Progro Ts
7. Trenbolone
8. Trenbolone Acetate, (17beta)-isomer
9. Trienbolone
10. Trienbolone Acetate
1. 10161-34-9
2. Finaplix
3. Trenbolone 17-acetate
4. Trenbolone (acetate)
5. Ru-1697
6. [(8s,13s,14s,17s)-13-methyl-3-oxo-2,6,7,8,14,15,16,17-octahydro-1h-cyclopenta[a]phenanthren-17-yl] Acetate
7. Trenbolone Acetate Ciii
8. Rud5y4sv0s
9. 17-beta-(acetyloxy)estra-4,9,11-trien-3-one
10. Trienbolone Acetate
11. Estra-4,9,11-trien-3-one, 17-(acetyloxy)-, (17b)-
12. Ncgc00167439-01
13. Component T-s
14. Finaplix H
15. Component T-h
16. Trenbolone Acetate [usan]
17. Einecs 233-432-5
18. Unii-rud5y4sv0s
19. Ru 1697
20. Brn 2012395
21. Estra-4,9,11-trien-3-one, 17-(acetyloxy)-, (17.beta.)-
22. 3-oxo-17beta-acetoxyestra-4,9,11-triene
23. Trenbolone Acetate [usan:usp]
24. Trenbolone-acetate
25. Finaplix (tn)
26. 17-beta-acetoxy-delta-4,9,11-estratrien-3-one
27. 17-beta-hydroxyestra-4,9,11-trien-3-one Acetate
28. 17beta-hydroxyestra-4,9,11-trien-3-one, Acetate
29. 17beta-hydroxyestra-4,9,11-trien-3-one 17-acetate
30. Revalor-h
31. Trenbolone 17
32. A-acetate
33. 17.beta.-hydroxyestra-4,9,11-trien-3-one, Acetate
34. Trenbolone Acetate (usp)
35. Dsstox_cid_26626
36. Dsstox_rid_81775
37. Dsstox_gsid_46626
38. Ru1697
39. Schembl139877
40. Trenbolone Acetate [mi]
41. Chembl1698011
42. Dtxsid2046626
43. Estra-4,9,11-trien-3-one, 17-beta-hydroxy-, Acetate
44. Chebi:192671
45. Estra-4,9,11-trien-3-one, 17-(acetyloxy)-, (17beta)-
46. Trenbolone Acetate [mart.]
47. Bcp11574
48. Trenbolone Acetate [who-dd]
49. Zinc4083873
50. Tox21_112443
51. Bdbm50190646
52. S4795
53. Akos015895158
54. Ccg-267604
55. Cs-3362
56. Db14660
57. Ds-8264
58. Trenbolone Acetate [green Book]
59. Ncgc00167439-03
60. Trenbolone Acetate [usp Impurity]
61. Trenbolone Acetate Ciii [usp-rs]
62. Hy-12360
63. Trenbolone Acetate [usp Monograph]
64. Cas-10161-34-9
65. D06211
66. 161t349
67. Trenbolone-acetate 100 Microg/ml In Acetonitrile
68. Q27288295
69. Trenbolone-acetate. Short Expiry Date Due To Chemical Nature Of Component(s)
70. (8s,13s,14s,17s)-13-methyl-3-oxo-2,3,6,7,8,13,14,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-17-yl Acetate
Molecular Weight | 312.4 g/mol |
---|---|
Molecular Formula | C20H24O3 |
XLogP3 | 2.5 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 2 |
Exact Mass | 312.17254462 g/mol |
Monoisotopic Mass | 312.17254462 g/mol |
Topological Polar Surface Area | 43.4 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 666 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anabolic Agents
These compounds stimulate anabolism and inhibit catabolism. They stimulate the development of muscle mass, strength, and power. (See all compounds classified as Anabolic Agents.)
VMF Number : 6191
Submission : 2017-05-16
Status : Active
Type : II
Available Reg Filing : ROW |
Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.
NDC Package Code : 24823-912
Start Marketing Date : 2010-03-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
VMF Number : 6053
Submission : 2013-07-10
Status : Active
Type : II
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16347
Submission : 2003-01-03
Status : Inactive
Type : II